Loading insider details...
Beta
Latest Form 4 (Mar 27, 2026): Exercise/Conversion of 24,000 PTGX shares, $309.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 27, 2026 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 24,000 | $309.1K |
| Jan 13, 2026 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 14,299 | $60.2K |
| Jan 7, 2026 | Protagonist Therapeutics, Inc (PTGX) | Grant/Award | 2,695 | n/a |
| Apr 30, 2025 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 10,725 | $12.4K |
| Jan 6, 2025 | Protagonist Therapeutics, Inc (PTGX) | Grant/Award | 5,130 | n/a |
| Sep 30, 2024 | Molecular Templates, Inc. (MTEM) | Grant/Award | 1,000 | n/a |
| Mar 12, 2024 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 6,490 | $12.3K |
| Jan 5, 2024 | Protagonist Therapeutics, Inc (PTGX) | Grant/Award | 25,700 | n/a |
| Apr 11, 2023 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 6,196 | $5.4K |
| Jan 19, 2023 | Protagonist Therapeutics, Inc (PTGX) | Grant/Award | 30,000 | n/a |